Ad
related to: dengue treatment infection
Search results
Results from the WOW.Com Content Network
5,000 per year (2023) [ 7 ] Dengue fever is a mosquito-borne disease caused by dengue virus, prevalent in tropical and subtropical areas. It is frequently asymptomatic; if symptoms appear they typically begin 3 to 14 days after infection. These may include a high fever, headache, vomiting, muscle and joint pains, and a characteristic skin ...
The main things you can do to keep yourself safe are “wearing mosquito repellent, avoiding areas known to harbor a lot of mosquitoes and wearing clothing that doesn’t expose a lot of skin ...
Dengue vaccine. Dengue vaccine is a vaccine used to prevent dengue fever in humans. [9] Development of dengue vaccines began in the 1920s, but was hindered by the need to create immunity against all four dengue serotypes. [10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [11][12]
The most common symptom of dengue is fever (which can range from mild to 104 degrees) and other symptoms, including: Muscle aches and pains. Pain behind the eyes. Bone pain (leading to its common ...
Dengue virus (DENV) is the cause of dengue fever.It is a mosquito-borne, single positive-stranded RNA virus of the family Flaviviridae; genus Flavivirus. [1] [2] Four serotypes of the virus have been found, and a reported fifth has yet to be confirmed, [3] [4] [5] all of which can cause the full spectrum of disease. [1]
Dengue fever infections have skyrocketed as many nations have reported increasingly hot temperatures, which create ideal conditions for the mosquitoes that spread dengue to hatch en masse and ...
Dengue is a Flaviviridae virus, with five genetic types. [8] [9] Here is the virus drawn as a 3-dimensional model of the envelope protein. [10] Dengue is in the same family as other well known viruses carried by mosquitoes that cause tropical diseases, such as yellow fever, West Nile, and Zika virus. [11]
The FDA has granted Fast Track Designation for Atea Pharmaceuticals Inc's (NASDAQ: AVIR) AT-752 for treating dengue virus infection. AT-752, a novel, orally administered direct-acting antiviral ...
Ad
related to: dengue treatment infection